BioSpace Announces Inaugural 40 Under 40 Winners

DES MOINES, Iowa, Oct. 7, 2025 /PRNewswire/ -- BioSpace, the leader in biopharma news and careers, has revealed the 2025 cohort for its inaugural 40 Under 40 list.

BioSpace's 40 Under 40 honors exemplary biotech and pharma professionals who have distinguished themselves in their companies and their field. The young leaders demonstrate innovation, business impact and commitment to improving outcomes for patients.­­­

"These individuals demonstrate why the biopharma industry will continue to persevere—determination to improve health through innovation, creativity and leading with conviction," said Josh Goodwin, BioSpace CEO. "Their outstanding careers, entrepreneurship and achievements are a testament to the grit of our industry."

40 Under 40 winners hail from a range of therapeutic areas and business functions. The 2025 cohort winners are:

• Tetiana Aleksandrova, CEO and Co-Founder, Subsense
• Kristen Anderson, Associate General Counsel, Verona Pharma
• Nkiru Anyagaligbo, Digital Lead – Rare, Apellis
• Andrew Barnhill, Head of Public Policy and Government Affairs, IQVIA
• Daniel Barvin, Vice President of Operations and Patient Advocacy, Coya Therapeutics
• Neena Bitritto-Garg, Founder, President and CEO, Ensho Therapeutics
• Francesco Borriello, Executive Director, Early-Stage Biology and Discovery Lead, Generate:Biomedicines
• Shelley Brathwaite, Director Patient Marketing Oncology, Sumitomo Pharma America
• Lena Ceballos, Manager, Corporate Communications and Marketing, Arcturus Therapeutics
• Alexandra Collin de l'Hortet, Vice President of Therapeutics, Epicrispr Biotechnologies
• Ashley Craddick, Senior Director of Operations for AAV Manufacturing, Forge Biologics
• David de Vries, Co-founder and CEO, Tr1x Bio
• Jacob Donoghue, CEO and Co-Founder, Beacon Biosignals
• William Eberley, Executive Director, Manufacturing Science and Technology, Vertex Pharmaceuticals
• Evan Feinberg, CEO, Genesis Therapeutics
• Ye Fu, Co-Founder and Chief Scientific Officer, Stellaromics
• Fabian Gerlinghaus, CEO and Co-Founder, Cellares
• Peyton Greenside, CEO and Co-Founder, BigHat Biosciences
• Michael Henderson, CEO, Apogee Therapeutics
• Katie Jorgensen, Vice President, Site Head, Basecamp, ElevateBio
• Prineeta Kulkarni, Head of Strategy and Corporate Development, Vedanta Biosciences
• Benjamine Liu, CEO and Co-Founder, Formation Bio
• Sean McClain, Founder and CEO, Absci
• Benjamin Oakes, CEO and Co-Founder, Scribe Therapeutics
• Kevin Parker, CEO and Co-Founder, Cartography Biosciences
• Darshil Patel, Director of Research and Development, COUR
• Dina Radenkovic, CEO and Co-Founder, Gameto
• Nabiha Saklayen, CEO and Co-Founder, Cellino Biotech
• Janine Sengstack, Co-Founder and Chief Scientific Officer, Junevity
• Ananth Sridhar, Chief Operating Officer, Cardiorenal, BridgeBio
• Benjamin Stone, Chief Business Officer, AnaptysBio
• Samantha Tabone, General Partner, XEIA Venture Partners; Head of Business Development, Xylo Bio
• Hok Hei Tam, Chief Technology Officer, Montai Therapeutics; Senior Principal, Flagship Pioneering
• Shilpa Tekula, Medical Director, Novartis Pharmaceuticals
• Alex Tilley, Senior Vice President, Advanced Analytics and Strategic Operations, BioCryst Pharmaceuticals
• Raphael Townshend, CEO and Founder, Atomic AI
• Tyler Van Horn, CEO, Science 37
• Niels Vande Casteele, Vice President, Early Clinical Development and Pharmacology, Mirador Therapeutics
• Angela Yen, Vice President, Data and Computational Sciences, Vertex Pharmaceuticals
• Xiao Zhang, Head of Global Pipeline Commercialization and Strategy for Gastroenterology, AbbVie

About 40 Under 40
Nominations for 40 Under 40 were open from May 1 to Aug. 1. To be eligible, nominees had to be based in the U.S.; be 39 years of age or younger for the calendar year for which they are considered; work in a leadership role in any size biotech or pharma company operating in the U.S.; and be employed at the company for which they were nominated when winners are announced. Anyone could nominate an individual for consideration, and nominees from all disciplines were welcome. Nominees were required to complete an online submission.

About BioSpace
BioSpace is the hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe through news, webinars, podcasts, email, advertising and jobs. Learn more and subscribe at biospace.com.

SOURCE BioSpace